Results 271 to 280 of about 9,386,140 (320)

Distinction Between Dysplasia, Malformation, and Deformity-Towards the Proper Diagnosis and Treatment of Hip Development Disorders. [PDF]

Diagnostics (Basel)
Dygut J, Piwowar M.
europepmc   +1 more source

Therapeutic potential and challenges of mesenchymal stem cells in neurological disorders: A concise analysis. [PDF]

J Neuropathol Exp Neurol
Issa EHB, Alghazo EM, Gharaibeh R, Momani NB, Taha DZ, Jaradat RJ, Alzu'bi A, Almahasneh FA, Abu-El-Rub E, Al-Zoubi RM.   +9 more
europepmc   +1 more source

Sleep disorders in cancer: interactions and intrinsic links. [PDF]

Front Oncol
Han C, Li N, Wang X, Zhuang Z, Cao Q, Wang S.   +5 more
europepmc   +1 more source

Stem cell treatments for female reproductive disorders: a comprehensive review. [PDF]

J Ovarian Res
Nair R, Agarwal P, Gadre MA, Vasanthan KS, Seetharam RN.   +4 more
europepmc   +1 more source

Genetic skeletal disorders: phenotypic-genotypic characteristics and RhGH therapy responses of a pediatric cohort. [PDF]

Sci Rep
Huang Y, Peng Y, Li C, Xie B, Wei X, Gui B, Meng J, Chen S, Fan X.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Growth and Growth Disorders in Children and Adolescents

Pediatric Annals, 2012
Evaluation of a child’s growth is one of the most important aspects of the general pediatric visit. Concerns about abnormal growth are the leading reasons general pediatricians refer patients to a pediatric endocrinologist. There is wide variation in normal growth patterns and an even greater variety of conditions that manifest with growth ...
Robert Rapaport, Evan Graber
openaire   +4 more sources

Therapy of growth disorders

Current Opinion in Endocrinology, Diabetes & Obesity, 2011
We review recent developments in the therapy of growth disorders, focusing mainly on recent developments in the field of growth hormone (GH) therapy.Review of current practice reveals wide variation in the approach to short stature and the institution of GH therapy.
Omar Ali, David Wyatt
openaire   +4 more sources

Pharmacogenomics Related to Growth Disorders

Hormone Research in Paediatrics, 2013
Growth disorders resulting in short stature are caused by a wide range of underlying pathophysiological processes. To improve height many of these conditions are treated with recombinant human growth hormone (rhGH). However, substantial inter-individual variability in growth response both in the short and long-term is recognised.
Stevens, A., De Leonibus, C., Whatmore, A., Hanson, D., Murray, P., Chatelain, P., Westwood, M., Clayton, P.   +7 more
openaire   +3 more sources

Management of Growth Disorders in Puberty: GH, GnRHa and Aromatase Inhibitors: A Clinical Review.

Endocrine reviews, 2022
Pubertal children with significant growth retardation represent a considerable therapeutic challenge. In growth hormone (GH) deficiency, and in those without identifiable pathologies (idiopathic short stature), the impact of using GH is significantly ...
N. Mauras, Judith L. Ross, V. Mericq
semanticscholar   +1 more source

Imprinted disorders and growth

Annales d'Endocrinologie, 2017
Fetal growth is a complex process. Its restriction is associated with morbidity and long-term metabolic consequences. Imprinted genes have a critical role in mammalian fetal growth. Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syndrome (SRS) are two imprinting disorders with opposite fetal growth disturbance.
Giabicani, Eloïse, Brioude, Frédéric, Le Bouc, Yves, Netchine, Irène   +3 more
openaire   +4 more sources